The Global Psychedelic Survey 2025: Capturing Worldwide Experiences

The Global Psychedelic Survey 2025 (GPS 2025) is a groundbreaking initiative launched by the Michigan Psychedelic Center at the University of Michigan. Running from May 1 to May 16, this international study seeks to gather real-world data on the use of psychedelic substances from diverse populations around the globe.

A Truly Global Effort

Building on the success of the 2023 survey, which collected over 6,000 responses largely from English-speaking countries, GPS 2025 dramatically expands its reach. This year’s survey is available in 18 languages—including Arabic, Chinese, Farsi, French, German, Hebrew, Japanese, Portuguese, Spanish, and more—in an effort to capture a broader, more culturally representative picture of psychedelic use worldwide.

What the Survey Covers

The survey explores a range of topics to better understand how, why, and where psychedelics are being used:

  • Substance Types: Data is collected on psilocybin, LSD, MDMA, ketamine, ayahuasca, and other compounds.
  • Usage Contexts: Whether participants are microdosing, attending ceremonies, or using psychedelics therapeutically or recreationally.
  • Demographics: Age, gender, ethnicity, and other factors help map patterns across populations.
  • Health Outcomes: Includes both positive and adverse psychological and physical effects.
  • Cultural and Regional Differences: Looks at how geography and culture influence psychedelic experiences.

Participants must be at least 21 years old and have some prior experience with psychedelics. The survey is anonymous, voluntary, and takes about 30–40 minutes to complete.

The Researchers Behind GPS 2025

The survey is led by an international team of researchers including:

  • Jacob Aday, PhD – University of Michigan
  • Stephanie Lake, PhD – UCLA
  • Philippe Lucas, PhD – University of Michigan
  • Daniel Kruger, PhD – University of Buffalo

They are supported by more than 70 collaborators from across the world, including organizations like MAPS, ICEERS, and the OPEN Foundation.

Why It Matters

The 2023 edition of the survey offered insights into microdosing, chronic pain management, and how psychedelics are being used in place of traditional pharmaceuticals. This year, GPS 2025 digs even deeper—exploring topics like psychedelics and pregnancy, Indigenous use, and harm reduction practices. The findings will help shape the future of psychedelic science, influence public health strategies, and inform emerging policy decisions around the world.

How to Participate

If you’re 21 or older and have experience with psychedelics, your voice matters. Visit the Michigan Psychedelic Center’s website before May 16, 2025, to take the survey and help move the psychedelic conversation forward.

Related Articles

RAND Report: Veterans Support Psilocybin Therapy at the VA

RAND Report Finds Veterans Want a Bigger Role for Psychedelic Therapy at the VA A new RAND report gives us one of the clearest pictures…

Indiana Funds Psilocybin Research for Veterans, First Responders and Treatment-Resistant Depression

Indiana is not known for leading the country on drug-policy reform. Recreational cannabis remains illegal in the state, and psilocybin is still classified as a…

LSD: From Serendipity to Resurgence in Therapeutic Research

The story of LSD (lysergic acid diethylamide) is a tale of serendipity, scientific curiosity, and a tumultuous journey from the laboratory to countercultural icon. In…

Who Controls the Psychedelic Future? Why “Unruly” Psychedelics Resist Easy Answers

Psychedelics are no longer hiding at the edges of American culture. They are appearing in university research centers, clinical trials, religious communities, veterans’ advocacy campaigns,…

Optimi Health Opens Access to $100 Million for Psychedelic Drug Expansion

Optimi Health Corp. has established an equity line of credit worth up to US$100 million, giving the Canadian psychedelic drug manufacturer significant potential access to…